Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bo Kruse currently holds 240,000 shares of Y-mAbs Therapeutics, Inc. (YMAB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bo Kruse has been a net seller of YMAB stock. They have purchased $0 and sold $6.3M worth of shares.
Bo Kruse's most recent insider trade was on May 31, 2024, when they sold 31,371 shares at $0.00 per share.
Bo Kruse serves as Executive at Y-mAbs Therapeutics, Inc. (YMAB). They have executed 32 insider transactions totaling $6.3M over their tenure at the company.
Bo Kruse holds the position of Executive at Y-mAbs Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Bo Kruse has shown a selling trading pattern, with $0 in total purchases and $6.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Bo Kruse was on May 14, 2020, when they sold $1.4M worth of YMAB shares. This transaction involved 37,847 shares at $36.03 per share.
Bo Kruse currently owns 240,000 shares of Y-mAbs Therapeutics, Inc. (YMAB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bo Kruse's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bo Kruse has 32 Form 4 filings on record as an insider at Y-mAbs Therapeutics, Inc..
Set alerts for Bo Kruse and 40,000+ other insiders.